av/ocuphire-pharma--big.svg

COM:OCUPHIRE

Opus Genetics

  • Stock

USD

Last Close

1.33

23/10 20:00

Market Cap

42.77M

Beta: -

Volume Today

675.97K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
47.50K
-
47.50K
0%
0.50
-
average payables
171K
-
778K
354.97%
1.40M
79.82%
1.33M
5.18%
1.61M
21.45%
average receivables
62.50K
-
62.50K
0%
2.42M
-
3.59M
48.10%
book value per share
0.10
-
0.15
53.80%
0.10
31.80%
0.08
23.79%
0.61
680.39%
0.32
47.58%
-1.07
432.18%
-2.89
171.03%
1.50
151.78%
2.32
55.06%
2.31
0.36%
capex per share
-0.00
-
capex to depreciation
-8.33
-
capex to operating cash flow
0.01
-
capex to revenue
cash per share
0.15
-
0.19
27.14%
0.13
30.78%
0.09
27.30%
0.98
948.49%
0.45
54.33%
0.64
42.91%
3.52
450.28%
1.67
52.63%
2.14
28.50%
2.34
9.26%
days of inventory on hand
days payables outstanding
130.97K
-
days sales outstanding
44.42
-
44.70
0.63%
debt to assets
3.21
-
0.02
-
debt to equity
-0.76
-
0.02
-
dividend yield
earnings yield
-0.00
-
-0.00
3.77%
-0.00
45.81%
-0.00
39.56%
-0.01
1,395.31%
-0.01
2.67%
-0.14
1,317.41%
-1.04
650.69%
-1.02
1.93%
0.25
124.92%
-0.15
160.44%
enterprise value
31.47B
-
59.16B
87.97%
31.51B
46.75%
14.60B
53.66%
2.65B
81.87%
1.46B
44.82%
58.31M
96.01%
13.85M
76.25%
31.40M
126.72%
27.72M
11.72%
14.48M
47.75%
enterprise value over ebitda
-3.96K
-
-4.46K
12.50%
-1.73K
61.31%
-889.57
48.43%
-152.52
82.86%
-71.12
53.37%
-13.69
80.74%
-1.47
89.30%
-1.37
6.29%
1.52
210.81%
-1.37
190.13%
ev to operating cash flow
-3.94K
-
-5.36K
35.94%
-1.82K
66.11%
-1.10K
39.21%
-171.65
84.45%
-77.53
54.83%
-16.23
79.07%
-2.04
87.44%
-1.62
20.44%
1.94
219.46%
-13.03
772.54%
ev to sales
53.32
-
0.70
98.70%
0.76
9.30%
free cash flow per share
-0.06
-
-0.06
1.01%
-0.10
51.74%
-0.06
36.06%
-0.56
825.50%
-0.57
1.66%
-0.51
10.86%
-1.46
185.84%
-1.30
10.57%
0.72
155.07%
-0.05
107.17%
free cash flow yield
-0.00
-
-0.00
26.40%
-0.00
195.06%
-0.00
64.41%
-0.01
541.43%
-0.01
120.82%
-0.07
420.82%
-0.22
236.49%
-0.35
55.61%
0.20
158.19%
-0.02
108.41%
graham net net
0.15
-
0.19
27.14%
0.13
30.78%
0.09
27.30%
0.98
948.49%
0.45
54.33%
-0.66
247.14%
-3.16
380.71%
1.41
144.46%
2.19
55.36%
2.23
2.18%
graham number
0.40
-
0.60
48.01%
0.43
28.48%
0.27
35.69%
3.57
1,197.57%
1.78
50.22%
5.04
183.87%
20.95
315.73%
11.32
45.97%
6.84
39.53%
4.90
28.34%
income quality
0.84
-
0.60
29.08%
1.21
102.35%
0.61
-
1.31
115.07%
0.58
55.58%
0.28
52.60%
0.34
23.76%
0.80
134.21%
0.11
86.08%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-2.98
-
-2.92
2.00%
-11.35K
389,175.68%
2.03K
117.84%
interest debt per share
1.01
-
1.47
45.91%
0.04
97.52%
0.00
98.76%
inventory turnover
invested capital
-0.76
-
0.02
-
market cap
31.49B
-
59.17B
87.89%
31.52B
46.74%
14.61B
53.64%
2.66B
81.83%
1.47B
44.67%
54.18M
96.31%
30.25M
44.17%
55.40M
83.14%
70.36M
27.00%
64.99M
7.63%
net current asset value
19.30M
-
33.43M
73.25%
24.66M
26.23%
20.92M
15.15%
28.14M
34.47%
15.90M
43.49%
-7.58M
147.69%
-13.48M
77.80%
22.21M
264.77%
46.23M
108.14%
49.91M
7.94%
net debt to ebitda
2.35
-
0.74
68.53%
0.56
24.59%
0.71
26.32%
0.51
27.31%
0.43
16.97%
-0.97
327.81%
1.74
278.93%
1.05
39.52%
-2.34
323.04%
4.78
304.34%
net income per share
-0.07
-
-0.11
42.43%
-0.08
25.01%
-0.04
45.73%
-0.92
2,057.52%
-0.44
52.73%
-1.06
142.59%
-6.75
537.69%
-3.81
43.63%
0.90
123.58%
-0.46
151.54%
operating cash flow per share
-0.06
-
-0.06
1.01%
-0.10
51.74%
-0.06
36.06%
-0.56
825.50%
-0.57
1.66%
-0.51
11.48%
-1.46
187.83%
-1.30
10.57%
0.72
155.07%
-0.05
107.17%
payables turnover
0.00
-
receivables turnover
8.22
-
8.17
0.63%
research and ddevelopement to revenue
25.76
-
0.36
98.60%
0.93
157.26%
return on tangible assets
-0.49
-
-0.55
13.71%
-0.58
4.99%
-0.44
23.73%
-0.89
102.17%
-0.90
0.16%
-4.21
370.02%
-1.78
57.71%
-2.17
21.79%
0.37
116.84%
-0.19
150.70%
revenue per share
0.04
-
2.00
4,941.84%
0.88
55.87%
roe
-0.75
-
-0.70
7.39%
-0.77
9.95%
-0.55
28.78%
-1.51
176.47%
-1.36
9.82%
0.99
173.03%
2.34
135.28%
-2.54
208.85%
0.39
115.21%
-0.20
151.72%
roic
-0.63
-
-0.50
21.01%
-0.97
94.85%
-0.96
1.08%
-1.03
7.56%
-1.94
87.87%
3.14
261.46%
1.90
39.61%
-0.99
152.48%
0.39
138.94%
-0.21
154.71%
sales general and administrative to revenue
13.79
-
0.18
98.68%
shareholders equity per share
0.10
-
0.15
53.80%
0.10
31.80%
0.08
23.79%
0.61
680.39%
0.32
47.58%
-1.07
432.18%
-2.89
171.03%
1.50
151.78%
2.32
55.06%
2.31
0.36%
stock based compensation to revenue
3.25
-
0.05
98.60%
tangible asset value
19.56M
-
33.53M
71.47%
24.81M
26.03%
21.04M
15.16%
28.29M
34.43%
16.04M
43.29%
-7.56M
147.12%
-13.47M
78.13%
22.22M
265.01%
46.24M
108.08%
49.91M
7.93%
tangible book value per share
0.15
-
0.19
25.26%
0.14
28.58%
0.10
28.84%
1.03
967.17%
0.49
52.81%
-1.07
318.71%
-2.89
171.03%
1.50
151.78%
2.32
55.06%
2.31
0.36%
working capital
19.30M
-
33.43M
73.25%
24.66M
26.23%
20.92M
15.15%
28.14M
34.47%
15.90M
43.49%
-7.58M
147.69%
14.48M
291.02%
22.21M
53.37%
46.23M
108.14%
49.91M
7.94%

All numbers in USD (except ratios and percentages)